サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1606411

ハイパーサーミアがん治療市場：装置タイプ別、治療タイプ別、用途別、エンドユーザー別、国別、地域別 - 産業分析、市場規模、市場シェア、予測、2024年～2032年

Hyperthermia Cancer Treatment Market, By Device Type, By Treatment Type, By Application, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日
ページ情報
英文 269 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
ハイパーサーミアがん治療市場：装置タイプ別、治療タイプ別、用途別、エンドユーザー別、国別、地域別 - 産業分析、市場規模、市場シェア、予測、2024年～2032年
出版日: 2024年11月04日
発行: AnalystView Market Insights
ページ情報: 英文 269 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レポートハイライト

ハイパーサーミアがん治療市場規模は2023年に1億8,921万米ドルと評価され、2024年から2032年にかけてCAGR 6.20％で拡大

ハイパーサーミアがん治療市場-市場ダイナミクス

世界のがん罹患率の増加が市場需要を促進すると予想されます。

世界のがんの罹患率は上昇傾向にあり、毎年数百万件の新規診断が報告されています。この増加傾向は、ハイパーサーミアのような先進治療など、より効果的で多様な治療選択肢の必要性を浮き彫りにしています。米国がん協会は、2023年には米国で新たに1,958,310人のがん患者が発生し、609,820人ががん関連で死亡すると予測しています。さらに、ハイパーサーミア技術の進歩や臨床研究の増加は、市場拡大の大きな機会をもたらす可能性があります。とはいえ、高コストと限られたアクセス性がこの成長を妨げる可能性もあります。

ハイパーサーミアがん治療市場-主要洞察

調査アナリストの分析によると、世界市場は予測期間（2024-2032年）に約6.20%のCAGRで毎年成長すると予測されます。

装置タイプ別では、マイクロ波ハイパーサーミアデバイスは2023年に最大の市場シェアを示すと予測されました。

用途別では、2023年に乳がんが主要タイプでした。

エンドユーザー別では、2023年には病院が主要タイプでした。

地域別では、北米が2023年の売上高でトップ

ハイパーサーミアがん治療市場-セグメンテーション分析：

ハイパーサーミアがん治療の世界市場は、装置タイプ、治療タイプ、用途、エンドユーザー、地域に基づいてセグメント化されます。

市場は装置タイプによって3つに区分される：マイクロ波ハイパーサーミア装置、超音波ハイパーサーミア装置、赤外線ハイパーサーミア装置、短波長ハイパーサーミア装置。マイクロ波ハイパーサーミア装置は市場で主導的地位を占めています。これらの装置は、マイクロ波エネルギーによって熱を発生させることによって機能し、一般に腫瘍組織の温度を上昇させることによって、特にがん細胞を標的にして除去することを目的としています。

市場は治療タイプによって2つのセグメントに分類される：小さな局所ハイパーサーミア、局所ハイパーサーミア、全身ハイパーサーミアです。実行可能な代替治療としてのハイパーサーミアの理解と受容が進むにつれて、局所ハイパーサーミア、局所ハイパーサーミア、全身ハイパーサーミアの各治療市場は大きな進展と革新を遂げると予想されます。

市場は用途によって2つのセグメントに分類される：乳がん、肝臓がん、軟部肉腫、頭頸部腫瘍、前立腺がんです。乳がんは市場拡大の主要因です。ハイパーサーミア療法は、放射線療法や化学療法の効果を高めるために腫瘍組織の温度を上昇させるもので、乳がん患者の重要な補助治療となっています。

市場はエンドユーザーによって3つのカテゴリーに区分される：病院、診療所、調査機関、がんセンターです。市場をリードするのは病院部門です。ハイパーサーミアがん治療市場は、病院内で重要性を増しており、この先進療法はがん治療プロトコルに不可欠な要素として認知されつつあります。

ハイパーサーミアがん治療市場-地理的洞察

地域的には、この市場は北米、ラテンアメリカ、欧州、アジア太平洋、中東・アフリカの各地域に広がっています。これらの地域は、ビジネスをもたらす国によってさらに分けられます。北米は、先進ヘルスケア施設と研究開発に力を入れているため、市場の成長を支配すると予想されます。北米には、最先端の医療技術とインフラを備えた世界有数のヘルスケア施設があります。このため、ハイパーサーミア治療を効果的に実施することができます。ヘルスケア業界の統計によると、2022年末には米国はヘルスケアに4兆5,000億米ドルを費やします。米国は現在、世界最大のヘルスケア支出国です。米国の最新のヘルスケアデータとレポートによると、2021年の同国全体の支出は4兆3,000億米ドル、GDPの18.5％に相当します。北米には、がん研究の最前線に立つ著名な研究機関や大学がいくつもあります。欧州は、ハイパーサーミア療法に対する意識の高まりにより、市場成長率で第2位の地域となっています。

ハイパーサーミアがん治療市場-競合情勢：

ハイパーサーミアがん治療市場は、その発展に重要な役割を果たす多様な主要企業や組織によって特徴付けられます。数多くの製薬企業が、化学療法や免疫療法と組み合わせた場合の温熱療法の有効性を改善することを目的とした調査に従事しています。治療プロトコルを改良するために、機器メーカーとの提携も盛んです。さまざまな市場への参入に成功し、自社製品の入手可能性を保証する企業が競争優位を握ることになります。これには、コスト関連の課題に取り組み、さまざまな地域で製品を入手できるようにすることが含まれます。最先端のがん治療に対する需要が高まり続ける中、競合情勢は変化し、適応能力と革新性に基づいて成功する企業が現れると予想されます。

目次

第1章 ハイパーサーミアがん治療市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 ハイパーサーミアがん治療の主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 ハイパーサーミアがん治療産業の調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しマッピング
  • 規制枠組み分析

第5章 ハイパーサーミアがん治療市場： COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19後の影響分析

第6章 ハイパーサーミアがん治療市場情勢

  • 温熱療法によるがん治療の市場シェア分析、2023年
  • 主要メーカー別内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 ハイパーサーミアがん治療市場- 装置タイプ別

  • 概要
    • セグメントシェア分析
    • マイクロ波ハイパーサーミア装置
    • 超音波ハイパーサーミア装置
    • 赤外線ハイパーサーミア装置
    • 短波ハイパーサーミア装置

第8章 ハイパーサーミアがん治療市場-治療タイプ別

  • 概要
    • 治療タイプ別セグメントシェア分析
    • 小さな局所ハイパーサーミア
    • 局所ハイパーサーミア
    • 全身ハイパーサーミア

第9章 ハイパーサーミアがん治療市場- 用途別

  • 概要
    • セグメントシェア分析
    • 乳がん
    • 肝臓がん
    • 軟部肉腫
    • 頭頸部腫瘍
    • 前立腺がん

第10章 ハイパーサーミアがん治療市場- エンドユーザー別

  • 概要
    • セグメントシェア分析
    • 病院
    • クリニック
    • 調査機関
    • がんセンター

第11章 ハイパーサーミアがん治療市場-地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋地域
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東およびアフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第12章 主要ベンダー分析- ハイパーサーミアがん治療業界

  • 競合ダッシュボード
  • 企業プロファイル
    • Andromedic Srl
    • Oncotherm Kft
    • YAMAMOTO VINITA CO., LTD
    • Alba Hyperthermia System
    • Sensius, MagForce AG
    • Celsius42 GmbH
    • Pyrexar Medical
    • Nanoprobes
    • Novavida
    • Hydrosun GmbH
    • Chongqing Haifu Medical Technology Co., Ltd.
    • RanD
    • Gamida
    • Others

第13章 アナリストの全方位展望

目次
Product Code: ANV4181

REPORT HIGHLIGHT

Hyperthermia Cancer Treatment Market size was valued at USD 189.21 Million in 2023, expanding at a CAGR of 6.20% from 2024 to 2032.

Hyperthermia is a therapeutic approach that involves elevating body tissue temperatures to as high as 113 °F, aiming to damage and eliminate cancer cells while minimizing harm to surrounding healthy tissue. This method, often referred to as thermal therapy, thermal ablation, or thermotherapy, is utilized to enhance the efficacy of other cancer treatments, such as radiation therapy or chemotherapy. In certain instances, the intense heat can completely eradicate cancer cells; however, it may also adversely affect normal cells and tissues.

Hyperthermia Cancer Treatment Market- Market Dynamics

The increasing prevalence of cancer worldwide is expected to propel market demand.

The worldwide incidence of cancer is on the rise, with millions of new diagnoses reported annually. This escalating trend highlights the necessity for more effective and varied treatment alternatives, such as advanced therapies like hyperthermia. The American Cancer Society projects that in 2023, there will be 1,958,310 new cancer cases and 609,820 cancer-related deaths in the United States. Additionally, advancements in hyperthermia technology and an increase in clinical research may present significant opportunities for market expansion. Nevertheless, high costs and limited accessibility could hinder this growth.

Hyperthermia Cancer Treatment Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 6.20% over the forecast period (2024-2032)

Based on Device Type segmentation, Microwave Hyperthermia Device was predicted to show maximum market share in the year 2023

Based on Application segmentation, Breast Cancer was the leading type in 2023

Based on End-User segmentation, the hospital was the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

Hyperthermia Cancer Treatment Market- Segmentation Analysis:

The Global Hyperthermia Cancer Treatment Market is segmented based on Device Type, Treatment Type, Application, End-User, and Region.

The market is segmented into three categories according to Device Type: Microwave Hyperthermia Device, Ultrasound Hyperthermia Device, Infrared Hyperthermia Device, and Short-wave Hyperthermia Device. The Microwave Hyperthermia Device holds a leading position in the market. These devices function by producing heat through microwave energy, which is specifically aimed at targeting and eliminating cancer cells, generally by increasing the temperature of tumor tissues.

The market is classified into two segments according to Treatment Type: Local Hyperthermia, Regional Hyperthermia, and Whole Body Hyperthermia. As the understanding and acceptance of hyperthermia as a viable treatment alternative grow, it is anticipated that the market for local, regional, and whole-body hyperthermia therapies will experience considerable progress and innovation.

The market is classified into two segments according to application: Breast Cancer, Liver Cancer, Soft Tissue Sarcoma, Head and Neck Tumors, and Prostate Cancer. Breast Cancer is the primary driver of market expansion. Hyperthermia therapy entails elevating the temperature of tumor tissues to enhance the efficacy of radiation and chemotherapy, thereby serving as a significant supplementary treatment for patients with breast cancer.

The market is segmented into three categories according to the end-user: Hospitals, Clinics, Research Institutes, and Cancer Centers. The hospital sector leads the market. The Hyperthermia Cancer Treatment Market is gaining significant importance within hospitals, where this advanced therapy is increasingly recognized as an essential element of cancer treatment protocols.

Hyperthermia Cancer Treatment Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to dominate the growth of the market, due to Advanced Healthcare facilities and a strong focus on research and development. North America is home to some of the most advanced healthcare facilities in the world, equipped with cutting-edge medical technology and infrastructure. This enables the effective implementation of hyperthermia treatment. According to healthcare industry statistics, at the end of 2022, the US will spend USD 4.5 trillion on healthcare. The United States currently has the greatest overall healthcare spending in the world. According to the most recent healthcare in the United States data and reports, the country's overall spending in 2021 will be USD 4.3 trillion, or 18.5% of GDP. North America boasts several prominent research institutions and universities that are at the forefront of cancer research. Europe holds the second largest region for market growth, due to rising awareness about Hyperthermia therapy.

Hyperthermia Cancer Treatment Market- Competitive Landscape:

The hyperthermia cancer treatment market is characterized by a diverse array of key players and organizations that play a significant role in its advancement. Numerous pharmaceutical companies are engaged in research aimed at improving the effectiveness of hyperthermia when combined with chemotherapy or immunotherapy. Partnerships with device manufacturers are prevalent to refine treatment protocols. Firms that successfully penetrate various markets and guarantee the accessibility of their products will hold a competitive advantage. This involves tackling cost-related challenges and ensuring product availability across different regions. As the demand for cutting-edge cancer therapies continues to rise, the competitive landscape is expected to transform, with successful entities emerging based on their capacity to adapt and innovate.

Recent Developments:

Pyrexar Medical has declared a new distribution alliance with Clinitech Co. Ltd., which will facilitate the introduction of Pyrexar's hyperthermia technologies in Cuba, the West Indies, Panama, and Venezuela.

Celsius42 GmbH, a prominent producer of hyperthermia systems for oncology applications, has established a comprehensive, long-term strategic partnership with the Lootah Group based in Dubai.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL HYPERTHERMIA CANCER TREATMENT MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Andromedic S.r.l.
  • Oncotherm Kft
  • YAMAMOTO VINITA CO., LTD
  • Alba Hyperthermia System
  • Sensius, MagForce AG
  • Celsius42 GmbH
  • Pyrexar Medical
  • Nanoprobes
  • Novavida
  • Hydrosun GmbH
  • Chongqing Haifu Medical Technology Co., Ltd.
  • RanD
  • Gamida
  • Others

GLOBAL HYPERTHERMIA CANCER TREATMENT MARKET, BY DEVICE TYPE- MARKET ANALYSIS, 2019 - 2032

  • Microwave Hyperthermia Device
  • Ultrasound Hyperthermia Device
  • Infrared Hyperthermia Device
  • Short-wave Hyperthermia Device

GLOBAL HYPERTHERMIA CANCER TREATMENT MARKET, BY TREATMENT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Local Hyperthermia
  • Regional Hyperthermia
  • Whole Body Hyperthermia

GLOBAL HYPERTHERMIA CANCER TREATMENT MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Breast Cancer
  • Liver Cancer
  • Soft Tissue Sarcoma
  • Head & Neck Tumor
  • Prostate Cancer

GLOBAL HYPERTHERMIA CANCER TREATMENT MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Clinics
  • Research Institutes
  • Cancer Centers

GLOBAL HYPERTHERMIA CANCER TREATMENT MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Hyperthermia Cancer Treatment Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Hyperthermia Cancer Treatment Market Snippet by Device Type
    • 2.1.2. Hyperthermia Cancer Treatment Market Snippet by Treatment Type
    • 2.1.3. Hyperthermia Cancer Treatment Market Snippet by Application
    • 2.1.4. Hyperthermia Cancer Treatment Market Snippet by End-User
    • 2.1.5. Hyperthermia Cancer Treatment Market Snippet by Country
    • 2.1.6. Hyperthermia Cancer Treatment Market Snippet by Region
  • 2.2. Competitive Insights

3. Hyperthermia Cancer Treatment Key Market Trends

  • 3.1. Hyperthermia Cancer Treatment Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Hyperthermia Cancer Treatment Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Hyperthermia Cancer Treatment Market Opportunities
  • 3.4. Hyperthermia Cancer Treatment Market Future Trends

4. Hyperthermia Cancer Treatment Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Hyperthermia Cancer Treatment Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Hyperthermia Cancer Treatment Market Landscape

  • 6.1. Hyperthermia Cancer Treatment Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Hyperthermia Cancer Treatment Market - By Device Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Device Type, 2023 & 2032 (%)
    • 7.1.2. Microwave Hyperthermia Device
    • 7.1.3. Ultrasound Hyperthermia Device
    • 7.1.4. Infrared Hyperthermia Device
    • 7.1.5. Short-wave Hyperthermia Device

8. Hyperthermia Cancer Treatment Market - By Treatment Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Treatment Type, 2023 & 2032 (%)
    • 8.1.2. Local Hyperthermia
    • 8.1.3. Regional Hyperthermia
    • 8.1.4. Whole Body Hyperthermia

9. Hyperthermia Cancer Treatment Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 9.1.2. Breast Cancer
    • 9.1.3. Liver Cancer
    • 9.1.4. Soft Tissue Sarcoma
    • 9.1.5. Head & Neck Tumor
    • 9.1.6. Prostate Cancer

10. Hyperthermia Cancer Treatment Market - By End-User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
    • 10.1.2. Hospitals
    • 10.1.3. Clinics
    • 10.1.4. Research Institutes
    • 10.1.5. Cancer Centers

11. Hyperthermia Cancer Treatment Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Hyperthermia Cancer Treatment Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Hyperthermia Cancer Treatment Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Hyperthermia Cancer Treatment Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Hyperthermia Cancer Treatment Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Hyperthermia Cancer Treatment Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Hyperthermia Cancer Treatment Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. Andromedic S.r.l.
    • 12.2.2. Oncotherm Kft
    • 12.2.3. YAMAMOTO VINITA CO., LTD
    • 12.2.4. Alba Hyperthermia System
    • 12.2.5. Sensius, MagForce AG
    • 12.2.6. Celsius42 GmbH
    • 12.2.7. Pyrexar Medical
    • 12.2.8. Nanoprobes
    • 12.2.9. Novavida
    • 12.2.10. Hydrosun GmbH
    • 12.2.11. Chongqing Haifu Medical Technology Co., Ltd.
    • 12.2.12. RanD
    • 12.2.13. Gamida
    • 12.2.14. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us